Clinical laboratory and life sciences company


Curila K, Benesova L, Penicka M, Minarik M, Zemanek D, Veselka J, Widimsky P, Gregor P. Low Prevalence and Variable Clinical Presentation of Troponin I and Troponin T Gene Mutations in Hypertrophic Cardiomyopathy. Genet Test Mol Biomarkers. 2009 13, 647-650. IF 1,170

Pesek M, Benesova L, Belsanova B, Mukensnabl P, Bruha F, Minarik M. Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status. Anticancer Res. 2009, 29, 2767-2773. IF 1,428

Salek, C., Minarikova, P., Benesova, L., Nosek, V., Strnad, R., Zavoral, M., Minarik M. Mutation Status of K-Ras, P53 and Allelic Losses at 9p and 18q Are Not Prognostic Markers in Patients with Pancreatic Cancer, Anticancer Res. 2009 May;29(5):1803-10.

Prochazkova K, Pavlikova K, Minarik M, Sumerauer D, Kodet R, Sedlacek Z. Somatic TP53 mutation mosaicism in a patient with Li-Fraumeni syndrome. Am J Med Genet A. 2009, 149A, 206-211.